KMDA or PRTA: Which Is the Better Value Stock Right Now?
CORRECTION: Prothena Corp Q2 EPS $(0.36) Misses $(0.09) Estimate, Sales $1.010M Miss $28.295M Estimate
Prothena (NASDAQ:PRTA) Beats EPS but Misses Revenue in Mixed Q2 2026 Results
Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights
Prothena to Report Second Quarter 2026 Financial Results on August 6
UPDATED: Watching Prothena; Shares Spike Higher, Form4 Filing Shows William P. Scully Bought 100,000 Shares At An Average Price Of $9.81/Share
Earnings Beat: Prothena Corporation plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Citizens Maintains Market Outperform on Prothena Corp, Raises Price Target to $20
Prothena (NASDAQ:PRTA) Smashes Q1 Estimates on $50 Million Milestone Payment, Shares Steady
Prothena Corp Q1 EPS $0.60 Beats $(0.34) Estimate, Sales $51.084M Beat $1.010M Estimate
Wall Street Analysts Think Prothena (PRTA) Could Surge 120.19%: Read This Before Placing a Bet
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade
Prothena Announces up to $100 Million Share Repurchase Plan
Prothena shares are trading higher after the company announced a $100 million share buyback.
Prothena Announces $100M Share Buyback
Prothena Corporation plc Q4 2025 Earnings Call Summary
RBC Capital Maintains Sector Perform on Prothena Corp, Raises Price Target to $12
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.